Invention Application
- Patent Title: ANTI-CLDN-5 ANTIBODY, AND DRUG CONTAINING SAID ANTIBODY
-
Application No.: US16611678Application Date: 2018-04-26
-
Publication No.: US20200148765A1Publication Date: 2020-05-14
- Inventor: Masuo KONDOH , Kiyohito YAGI , Takefumi DOI , Yoshiaki OKADA , Yosuke HASHIMOTO , Tatsuya SAWASAKI , Hiroyuki TAKEDA , Kohki ENDO , Maki TAMURA
- Applicant: OSAKA UNIVERSITY , NATIONAL UNIVERSITY CORPORATION EHIME UNIVERSITY , FUJIFILM Wako Pure Chemical Corporation
- Applicant Address: JP Osaka JP Ehime JP Osaka
- Assignee: OSAKA UNIVERSITY,NATIONAL UNIVERSITY CORPORATION EHIME UNIVERSITY,FUJIFILM Wako Pure Chemical Corporation
- Current Assignee: OSAKA UNIVERSITY,NATIONAL UNIVERSITY CORPORATION EHIME UNIVERSITY,FUJIFILM Wako Pure Chemical Corporation
- Current Assignee Address: JP Osaka JP Ehime JP Osaka
- Priority: com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@38472539
- International Application: PCT/JP2018/016975 WO 20180426
- Main IPC: C07K16/28
- IPC: C07K16/28
Abstract:
An object of the present invention is to provide a novel molecule which has high specificity to CLDN-5 and recognizes an extracellular domain of CLDN-5. The object is achieved by an antibody which specifically recognizes a three-dimensional structure or a primary structure of an extracellular domain of a Claudin-5 protein.
Public/Granted literature
- US11053313B2 Anti-CLDN-5 antibody, and drug containing said antibody Public/Granted day:2021-07-06
Information query
